Upcoming Webinars

https://biopharmawebinars.com/webinars/validating-rcr-on-a-microfluidic-platform-a-multi-matrix-approach/

Validating rCR on a Microfluidic Platform: A Multi-Matrix Approach

Presented by Meg Provenzano, Global Product Manager for Endotoxin at Veolia
14th April 2026


https://biopharmawebinars.com/webinars/automation-traceability-reliability-see-our-lims-in-action/

Automation, Traceability, Reliability: See Our LIMS in Action

Presented by Albane Flocon, Bioinformatics developer at genOway, Christel Merrouche, Head of preclinical processes at genOway and Stéphane Pitout -  Director of Professional Sales (SciY)
22nd April 2026


https://biopharmawebinars.com/webinars/validation-and-implementation-of-the-monocyte-activation-test-as-an-alternative-method-to-the-rabbit-pyrogen-test/

Validation and Implementation of the Monocyte Activation Test as an Alternative Method to the Rabbit Pyrogen Test  

Presented by Jonas Van Den Berg, Subject Matter Expert, Pyrogen Testing and Alternative Microbiological Methods at Roche, Luisa Burgmaier, Project Leader, Endotoxin and Pyrogen Testing Group at Microcoat Biotechnologie
13th May 2026


https://biopharmawebinars.com/webinars/usp-general-chapter-665-separating-fact-from-fiction/

USP General Chapter <665>: Separating Fact from Fiction

Presented by Desmond G Hunt, Senior Principal Scientist at US Pharmacopeia, Dr. Samuel Kikandi, Deputy Director- Principal Engineer at Sanofi
20th May 2026


 

On Demand Webinars

https://biopharmawebinars.com/webinars/2part-live-webinar-series-iso-10993-updates-in-practice-from-el-testing-challenges-to-iso-1099312025-revisions/

2‑Part Live Webinar Series ISO 10993 Updates in Practice: From E&L Testing Challenges to ISO 10993‑1:2025 Revisions

Presented by Elisabet Jamez, Expert Advisory Services team at Nelson Labs and Wouter Buyssens, Scientific Project Manager at Nelson Labs
31st March 2026


https://biopharmawebinars.com/webinars/regulatory-challenges-of-recent-low-endotoxin-recovery-regulatory-queries-pfizers-strategy-to-evaluate-and-implement-global-changes-to-meet-evolving-expectations/

Regulatory Challenges of Recent Low Endotoxin Recovery Regulatory Queries: Pfizer’s Strategy to Evaluate and Implement Global Changes to Meet Evolving Expectations

Presented by Jody Peraino MS, Principal Scientist, Pfizer, Allen L. Burgenson, Global Subject Matter Expert, Testing Solutions at Lonza
20th March 2026


https://biopharmawebinars.com/webinars/considerations-for-mrna-lnp-potency-assay-development-for-gene-editing-products/

Considerations for mRNA-LNP Potency Assay Development for Gene Editing Products

Presented by Benjamin Hall, Associate Director in Analytical Development at Tessera Therapeutics, Gargi Chaudhuri, Ph.D., Senior Field Applications Scientist, Bio-Techne (Protein Simple) 
12th March 2026


https://biopharmawebinars.com/webinars/expanding-continuous-manufacturing-at-pfizer-enabling-high-drug-load-formulations-via-wet-granulation-technology/

Expanding Continuous Manufacturing at Pfizer, Enabling High Drug Load Formulations via Wet Granulation Technology

Presented by Travis Powell, Senior Principal Scientist at Pfizer
10th March 2026